Tao Capital Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,042
| Closed | -$66K | – | 11 |
|
|
2023
Q4 | $66K | Buy |
+3,042
| New | +$66K | 0.06% | 11 |
|
|
2023
Q3 | – | Sell |
-3,651
| Closed | -$108K | – | 12 |
|
|
2023
Q2 | $108K | Buy |
+3,651
| New | +$108K | 0.08% | 13 |
|
|
2021
Q4 | – | Sell |
-38,949
| Closed | -$1.97M | – | 16 |
|
|
2021
Q3 | $1.97M | Buy |
+38,949
| New | +$1.97M | 0.52% | 13 |
|
|
2021
Q2 | – | Sell |
-6,086
| Closed | -$348K | – | 10 |
|
|
2021
Q1 | $348K | Buy |
+6,086
| New | +$348K | 0.1% | 8 |
|